• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HLS
Click for more information
4.57% $1.20

HEALIUS LIMITED - Charts / Financials

Market Cap $873.1M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Healius Limited is an Australia-based healthcare company. The Company operates through... Healius Limited is an Australia-based healthcare company. The Company operates through two segments: Pathology and Imaging. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment is a provider of imaging and scanning services at standalone imaging sites, hospitals, and medical centers. The Company has a network of pathology laboratories, collection centers, and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. The Company’s brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. The Company provides healthcare services that are accessible and efficient while supporting the coordination and continuity of quality patient care.More

refresh Created with Sketch. REFRESH
Last update - 14.29pm 06/05/2024 (20 minute delay) ?
Day
Open $1.15   Day High $1.21   Day Low $1.14
Daily Volume 1796361
Bids   Sellers
Number Price Volume   Number Price Volume
18 $1.20 58414   34 $1.21 59101

Directors & Senior Management

Mr. Paul Anderson Chief Executive Officer, Managing Director
Mr. Stephen Humphries Chief Financial Officer, Joint Company Secretary, Group Executive, General Affairs
Mr. Prasad Arav Group Executive - Digital and Technology
Mr. Jon Eide Group Executive - Commercial and Customer
Dr. Phil Lucas Group Executive - Lumus Imaging
Mr. Arjun Narang Group Executive - Operations Transformation
Mr. Mark Neeham Group Executive - Government Affairs
Ms. Janet Payne Group Executive - Corporate Affairs
Dr. Jan Van Rooyen Group Executive, Healius Pathology
Ms. Mary Weaver Joint Company Secretary
Ms. Kathryn McKenzie Interim Non-Executive Independent Chairman of the Board
Mr. Ravi Jeyaraj Director
Dr. Michael Philip Stanford Non-Executive Director
Mr. Gordon Richard Davis Non-Executive Independent Director
Ms. Sally Louise Evans Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$1.20 		Change
0.053(4.57%) 		Mkt cap ! $873.1M
Open High Low Value Volume
$1.15 $1.21 $1.14 $2.121M 1.796M

Buyers (Bids)

No. Vol. Price($)
18 58414 $1.20
 

Sellers (Offers)

Price($) Vol. No.
$1.21 59101 34
View Market Depth
Last trade - 14.09pm 06/05/2024 (20 minute delay) ?
Last
$1.21 		  Change
0.053 ( 5.19 %)
Open High Low Volume
$1.15 $1.21 $1.14 835245
Last updated 14.29pm 06/05/2024 ?

Top Stories

Sold out signs go up for RIU Resources Roundup in Sydney

More than 115 companies will be participating in this year's RIU Resources Roundup in Sydney.
Mantle Minerals to kick off drilling at Mt Berghaus in WA Mantle Minerals (ASX:MTL) has announced it's kicking off a 122-hole drill run on-site its Mt Berghaus acreage in Western Australia.
Westpac tracks lower in profits in first half of 2024, with a 16% yoy drop amid slowing economy Westpac Banking Corporation has reported a 16 percent drop in net profit (to $3.342 billion) for the first half of the 2024 financial year compared to the same time last year.
Tamboran is listing on the NYSE, and Wall Street is paying attention If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.
Maiden drilling at West Arunta hints at major IOCG system for Rincon Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.